Companies Dominating the Predictive Biomarkers Landscape
- Siemens Healthcare GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Epigenomics AG
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN GmbH
- Danaher Corporation
- Biomarker Technologies, Inc.
- Almac Group Limited
- Myriad Genetics, Inc.
- Meso Scale Diagnostics, LLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of predictive biomarkers is evaluated at USD 31.92 billion.
The predictive biomarkers market size was over USD 24.12 billion in 2024 and is poised to exceed USD 226.46 billion by 2037, growing at over 18.8% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of chronic diseases, such as cancer, and diabetes across the globe and the growing geriatric population will boost the market growth.
North America industry is anticipated to account for largest revenue share of 35% by 2037, backed by advanced research and development activities in the healthcare sector.
The major players in the market are Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Epigenomics AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN GmbH, Danaher Corporation, Biomarker Technologies, Inc., Almac Group Limited, Myriad Genetics, Inc., Meso Scale Diagnostics, LLC
